The Mission of the new large-scale viral vector manufacturing facility will be to provide large quantities of high-quality recombinant adeno-associated virus (rAAV) vectors for preclinical research.  Our collaboration with Cytiva formerly GE Healthcare to create this large scale rAAV needed for preclinical research will advance the cell and gene therapy industry and get therapies to patients faster.  Accelerating research that brings novel cell and gene therapies to patients quicker is our mission.